Movie Industry

'Chiikawa' Attracted 56,000 Viewers in a Single Day… Remains Unchallenged at No. 1 at the Box Office

Brad Pitt's New Film 'Heart of the Beast' Ranks Second

Choi Hee-jae
2026-10-29 08:23:16
[Edaily Reporter Choi Hee-jae ] The Japanese animated film "Chiikawa: The Secret of the Mermaid Island" (Chiikawa) continues to dominate the box office, maintaining its top spot.
Still from the movie “Chiikawa: The Secret of Mermaid Island” (Photo courtesy of CJ ENM)

According to the Korean Film Council’s integrated computer network on the 29th, as of the 28th, “Chiikawa” drew 56,301 viewers on the 28th, securing the No. 1 spot at the box office. Its cumulative attendance stands at 2,342,823.

“Heart of the Beast,” starring Brad Pitt and released on the same day, drew 30,168 viewers, debuting in second place. Its cumulative attendance stands at 30,975.

The new film “The Secret Behind the College Entrance Exam,” starring Lee Sun-bin and Yoo Jae-myung, which opened on the 28th, ranked third with 14,332 daily viewers. Its cumulative total stands at 16,919.

The re-released Japanese animated film “Attack on Titan: The Arrow of Flame” drew 12,012 viewers, ranking fourth. Its cumulative attendance stands at 36,713. “The Assassin(s)” attracted 9,728 viewers that day, placing fifth. Its cumulative attendance stands at 3,399,183.

Economy

Corporation

IT·Science

Economy

UK Robot Startup Raises Record Amount… 53.5 Billion for 'AI That Learns by Watching'

A British startup that can teach robots new skills simply by showing them a human performing a task just once has successfully secured a large-scale investment. Expectations that this technology could…
2026-10-30 17:31:03

Corporation

SEMPIO FOODS to Merge with Holding Company ‘SEMPIO’… “To Streamline Management and Secure Future Growth Engines”

SEMPIO FOODS(248170)will merge with its holding company, SEMPIO. The plan is to streamline the holding company structure and reorganize the management structure around the operating company to enhance…
2026-10-30 17:53:20

IT·Science

Curocell Inc., Which Received Approval for Third-Line Treatment, Now Sets Its Sights on the Second-Line Treatment Market

Curocell Inc.(372320)is moving to expand the second-line treatment indication for “Limkato,” Korea’s first domestically developed chimeric antigen receptor T-cell (CAR-T) therapy.Curocell Inc. announc…
2026-10-30 17:31:04